Theragnostics combines therapy and diagnosis into a single, unified strategy for the management and treatment of disease. The Hull Molecular Imaging Centres (HuMIC) is currently implementing the latest clinically approved theragnostic technology into routine practice at Castle Hill Hospital and planning clinical trials for the benefit of patients in Hull, East Yorkshire and the surrounding area.
To progress our own research in this area and capitalise on our world-class expertise and scientific/clinical infrastructure, we recently formed the Hull University Theragnostics (HUT) cluster, to assemble four PhD studentships pioneering new theragnostic technology and its application to disease. HUT combines two of the most successful scientific research groups in the Faculty of Health Sciences: Molecular Imaging (led by Prof Steve Archibald & Dr Louis Allott) and the Wound Healing research group (led by Prof Mat Hardman & Dr Holly Wilkinson). Together, with the four excellent PhD candidates we seek to recruit, we will explore new and unique scientific ground in the burgeoning field of theragnostics so that we can improve patient health in the region and beyond.
Application deadline 10 February 2023.
Learn more about the individual scholarships:
For more information, why not watch a recording of the webinar we held on 6 December? You can find out more about each project and watch the question and answer after the presentations.